Form4insider filings, from the source

SEC Form 4 · accession 0001578563-15-000003

Nuo Therapeutics, Inc. · AURX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
B. Jefferson Clark
10% Owner · Other
Aldagen Holdings, LLC
10% Owner · Other
William W Brooke
10% Owner · Other
Period of report
Jan 13, 2015
Accepted (ET)
Jan 15, 2015 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 13, 2015S14,000$0.35D12,340,362D
Common StockF1Jan 14, 2015S153,467$0.35D12,186,895D
Common StockF2holding———108,830ISee Footnote 2
Common StockF3holding———157,276ISee Footnote 3
Common StockF4holding———175,533ISee Footnote 4
Common StockF5holding———429,404ISee Footnote 5
Common StockF6holding———60,494ISee Footnote 6

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to buy)F2$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock15,61615,616I
Warrant (right to buy)F3$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock22,56722,567I
Warrant (right to buy)F4$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock63,63663,636I
Warrant (right to buy)F5$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock63,63663,636I
Warrant (right to buy)F6$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock12,72712,727I

Explanation of responses